000 01468 a2200397 4500
005 20250514185226.0
264 0 _c20040621
008 200406s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/j.ejca.2004.01.024
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKemper, E M
245 0 0 _aImproved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_cMay 2004
300 _a1269-74 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aATP Binding Cassette Transporter, Subfamily B, Member 1
_xantagonists & inhibitors
650 0 4 _aAcridines
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBrain Chemistry
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCyclosporins
_xpharmacology
650 0 4 _aDocetaxel
650 0 4 _aDrug Interactions
650 0 4 _aFemale
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aTaxoids
_xadministration & dosage
650 0 4 _aTetrahydroisoquinolines
_xpharmacology
700 1 _aVerheij, M
700 1 _aBoogerd, W
700 1 _aBeijnen, J H
700 1 _avan Tellingen, O
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 40
_gno. 8
_gp. 1269-74
856 4 0 _uhttps://doi.org/10.1016/j.ejca.2004.01.024
_zAvailable from publisher's website
999 _c14821811
_d14821811